Biora Therapeutics | ARS: Annual Report to Security Holders
Apr 25 04:15
Biora Therapeutics | DEFA14A: Others
Apr 25 04:09
Biora Therapeutics | DEF 14A: Definitive information statements
Apr 25 04:06
Biora Therapeutics | EFFECT: Others
Apr 18 18:06
Biora Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 13 04:34
Biora Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Apr 9 04:13
Biora Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jeffrey A. Ferrell(49.9%),Athyrium Funds GP Holdings LLC(49.9%), etc.
Apr 3 08:46
Biora Therapeutics | 424B5: Prospectus
Apr 3 04:53
Biora Therapeutics | 8-K: Current report
Apr 3 04:51
Biora Therapeutics | 424B5: Prospectus
Apr 3 04:48
Biora Therapeutics | 424B5: Prospectus
Apr 3 04:46
Biora Therapeutics | 424B5: Prospectus
Apr 3 04:45
Biora Therapeutics | 424B5: Prospectus
Apr 3 04:41
Biora Therapeutics | 424B5: Prospectus
Apr 3 04:41
Biora Therapeutics | 10-K: Annual report
Apr 2 04:49
Biora Therapeutics | 424B5: Prospectus
Apr 2 04:05
Biora Therapeutics | 8-K: Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
Mar 27 04:16
Biora Therapeutics | SCHEDULE 13G: Others
Mar 21 06:33
Biora Therapeutics | 8-K: Current report
Mar 11 20:11
Biora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer MOHANTY ADITYA P.
Feb 16 05:09
No Data
No Data